Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Nuvasive Inc (NUVA)

Nuvasive Inc (NUVA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,270,901
  • Shares Outstanding, K 52,061
  • Annual Sales, $ 1,139 M
  • Annual Income, $ -64,090 K
  • 60-Month Beta 1.18
  • Price/Sales 2.01
  • Price/Cash Flow 9.24
  • Price/Book 2.77
Trade NUVA with:

Options Overview Details

View History
  • Implied Volatility 60.72% ( -1.89%)
  • Historical Volatility 42.81%
  • IV Percentile 65%
  • IV Rank 59.74%
  • IV High 77.85% on 05/10/22
  • IV Low 35.31% on 09/24/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 46
  • Put/Call OI Ratio 0.58
  • Today's Open Interest 884
  • Open Int (30-Day) 1,302

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate 0.53
  • Number of Estimates 7
  • High Estimate 0.66
  • Low Estimate 0.46
  • Prior Year 0.32
  • Growth Rate Est. (year over year) +65.63%

Price Performance

See More
Period Period Low Period High Performance
1-Month
41.33 +5.55%
on 09/01/22
49.46 -11.81%
on 09/12/22
-2.70 (-5.83%)
since 08/23/22
3-Month
41.33 +5.55%
on 09/01/22
54.62 -20.14%
on 08/15/22
-6.57 (-13.09%)
since 06/23/22
52-Week
41.33 +5.55%
on 09/01/22
64.43 -32.30%
on 09/28/21
-19.22 (-30.59%)
since 09/23/21

Most Recent Stories

More News
NuVasive to Participate as Double Diamond Sponsor at Scoliosis Research Society Annual Meeting

/PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive,...

NUVA : 43.62 (-0.71%)
NuVasive (NUVA) Down 16.2% Since Last Earnings Report: Can It Rebound?

NuVasive (NUVA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

NUVA : 43.62 (-0.71%)
NuVasive Announces Departure of Chief Commercial Officer

/PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive,...

NUVA : 43.62 (-0.71%)
NuVasive (NUVA) Q2 Earnings Miss Estimates, Revenues Beat

NuVasive's (NUVA) Q2 revenues outpaced the consensus mark with strong sales across U.S. Spinal Hardware and Surgical Support businesses.

MRK : 86.78 (-0.83%)
DGX : 122.35 (-0.40%)
MOH : 328.74 (-0.23%)
NUVA : 43.62 (-0.71%)
NuVasive (NUVA) Lags Q2 Earnings Estimates

NuVasive (NUVA) delivered earnings and revenue surprises of -14.55% and 1.51%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

NUVA : 43.62 (-0.71%)
RMD : 214.51 (+0.38%)
NuVasive Announces Second Quarter 2022 Financial Results

/PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive,...

NUVA : 43.62 (-0.71%)
MedTech Stocks to Watch for Earnings on Aug 3

MedTech players are likely to have benefited from the consistent opening of economies and sales contributions from high testing demand. Let's see how CRL, CVS, BRKR and NUVA fare this time.

CVS : 98.35 (-1.48%)
CRL : 187.51 (+1.45%)
NUVA : 43.62 (-0.71%)
BRKR : 49.52 (-0.40%)
Analysts Estimate MacroGenics (MGNX) to Report a Decline in Earnings: What to Look Out for

MacroGenics (MGNX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

MGNX : 3.04 (+1.00%)
NUVA : 43.62 (-0.71%)
Clinical Study Validates NuVasive Porous Interbody Implant and Synthetic Bone Graft Substitute as Cost-effective Solution for Lateral Lumbar Interbody Fusions

/PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive,...

NUVA : 43.62 (-0.71%)
NuVasive Announces Conference Call and Webcast of Second Quarter 2022 Results

/PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive,...

NUVA : 43.62 (-0.71%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

NuVasive, Inc. is one of the leading global medical device companies in the global spine market, focused on developing minimally-disruptive surgical products and procedurally-integrated solutions for the spine. The principal product offering includes a minimally-disruptive surgical platform called Maximum...

See More

Key Turning Points

3rd Resistance Point 45.45
2nd Resistance Point 44.57
1st Resistance Point 44.09
Last Price 43.62
1st Support Level 42.73
2nd Support Level 41.85
3rd Support Level 41.37

See More

52-Week High 64.43
Fibonacci 61.8% 55.60
Fibonacci 50% 52.88
Fibonacci 38.2% 50.15
Last Price 43.62
52-Week Low 41.33

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar